Event

This course provides an update on evolving trends in diagnosis, clinical management, and research investigation of the heterogeneous group of interstitial lung diseases (ILDs) of unknown etiology, in the setting of connective tissue diseases and granulomatous ILD (hypersensitivity pneumonitis and sarcoidosis) with an emphasis on idiopathic pulmonary fibrosis (IPF). This includes new data for the diagnosis of IPF since the 2011 guidelines and perspectives for the diagnosis and management of hypersensitivity pneumonitis. Genetic factors, precision medicine for diagnosis and treatment as well as newer concepts in the pathogenesis of IPF and novel treatment strategies to modulate pulmonary fibrosis will be discussed. Attendees will be updated on evolving enhanced knowledge in the clinical management of patients with ILD. The importance of making an accurate diagnosis will be demonstrated by live interactions with a panel of experts from multiple disciplines confronted with 3-4 cases unknown to them.